{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:45:56Z","timestamp":1758991556719,"version":"3.41.2"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Transdermal fentanyl (TDF) is a commonly used analgesic drug for managing moderate-to-severe chronic cancer pain. Similar to those observed during the administration of other opioid agonists, the most frequently observed adverse drug reactions during TDF administration include nausea, vomiting, and constipation. However, there have been no reports of TDF causing intestinal obstruction yet. We report a case of TDF-induced paralytic intestinal obstruction confirmed by clinical presentations and imaging findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We administered TDF (4.2\u00a0mg once every 72\u00a0h) for external use to a patient who was admitted with acute upper gastrointestinal bleeding, suffering from advanced liver cancer, and having previously received irregular analgesia. Despite achieving satisfactory analgesic effects, he developed nausea, vomiting, constipation, reduced anal exhaust, and absence of bowel sounds on the fifth day of TDF administration. An X-ray test revealed the presence of flatulence and signs of air fluid levels in the intestine. Conventional treatment was ineffective, and paralytic intestinal obstruction was finally alleviated only after TDF was substituted with oral morphine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings indicate that, even when TDF is administered in conventional doses, there is a risk of inducing rare cases of intestinal obstruction. In the event of such an occurrence, adjusting the analgesic treatment plan should be the utmost priority.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1550296","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:31:32Z","timestamp":1741174292000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Transdermal fentanyl induced paralytic intestinal obstruction in advanced liver cancer: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Chen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jindong","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00414-015-1209-z","article-title":"Death by band-aid: fatal misuse of transdermal fentanyl patch","volume":"129","author":"Bakovic","year":"2015","journal-title":"Int. J. Leg. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.legalmed.2010.03.001","article-title":"A fatality involving an unusual route of fentanyl delivery: chewing and aspirating the transdermal patch","volume":"12","author":"Carson","year":"2010","journal-title":"Leg. Med. (Tokyo)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/papr.12669","article-title":"Nonresponsiveness and susceptibility of opioid side effects related to cancer patients' clinical characteristics: a post-hoc analysis","volume":"18","author":"Corli","year":"2018","journal-title":"Pain. Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2147\/DDDT.S414318","article-title":"Guidelines for rational clinical use of fentanyl transdermal patch","volume":"18","author":"Fu","year":"2024","journal-title":"Drug. Des. devel. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s40264-023-01351-y","article-title":"Adverse drug reactions to opioids: a study in a national pharmacovigilance database","volume":"46","author":"Gustafsson","year":"2023","journal-title":"Drug. Saf."},{"key":"B6","doi-asserted-by":"publisher","first-page":"CD010270","DOI":"10.1002\/14651858.CD010270.pub2","article-title":"Transdermal fentanyl for cancer pain","volume":"2013","author":"Hadley","year":"2013","journal-title":"Cochrane. Database. Syst. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12664-018-0831-3","article-title":"Small intestine strictures in opium addicts: an unrecognized cause of intestinal obstruction","volume":"37","author":"Joshi","year":"2018","journal-title":"Indian. J. Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.14309\/ajg.0000000000002887","article-title":"Opioids and the gastrointestinal tract: the role of peripherally active \u00b5-opioid receptor antagonists in modulating intestinal permeability","volume":"119","author":"Lacy","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.5217\/ir.2019.00104","article-title":"Clinical profile and outcomes of opioid abuse gastroenteropathy: an underdiagnosed disease entity","volume":"18","author":"Mahajan","year":"2020","journal-title":"Intest. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2165\/00003495-200161150-00014","article-title":"Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control","volume":"61","author":"Muijsers","year":"2001","journal-title":"Drugs"},{"key":"B11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/2040622315627801","article-title":"Opioid-induced constipation: advances and clinical guidance","volume":"7","author":"Nelson","year":"2016","journal-title":"Ther. Adv. Chronic."},{"key":"B12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/BF03178274","article-title":"Transdermal fentanyl: pharmacology and toxicology","volume":"5","author":"Nelson","year":"2009","journal-title":"J. Med. Toxicol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s0885-3924(98)00100-6","article-title":"Heat-related toxicity with the fentanyl transdermal patch","volume":"16","author":"Newshan","year":"1998","journal-title":"J. Pain. Symptom. Manage."},{"key":"B14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/1752-1947-6-220","article-title":"Life-threatening coma and full-thickness sunburn in a patient treated with transdermal fentanyl patches: a case report","volume":"6","author":"Sindali","year":"2012","journal-title":"J. Med. Case. Rep."},{"key":"B15","unstructured":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents\n          \n          \n          2018"},{"key":"B16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11670-011-0317-7","article-title":"Multicenter clinical study for evaluation of efficacy and safety of transdermal fentanyl matrix patch in treatment of moderate to severe cancer pain in 474 Chinese cancer patients","volume":"23","author":"Zhu","year":"2011","journal-title":"Chin. J. Cancer. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1550296\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:31:34Z","timestamp":1741174294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1550296\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":16,"alternative-id":["10.3389\/fphar.2025.1550296"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1550296","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"article-number":"1550296"}}